Publication | Open Access
Optimal antiproteinuric dose of aliskiren in type 2 diabetes mellitus: a randomised crossover trial
31
Citations
9
References
2010
Year
Diabetes ManagementDiabetesPharmacologyType 2PharmacotherapyDiabetes MellitusMedicineRandomised Crossover Trial
| Year | Citations | |
|---|---|---|
Page 1
Page 1